BioCryst Pharmaceuticals (NASDAQ:BCRX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug ... American Banking News - Forex, 3 weeks ago
As 2015 comes to a close, youre sure to see quite a few Best of lists. Google today unveiled several of its own, included lists for its best Android apps and games of the year.… As 2015 comes to a close, youre sure to see quite a few Best of ...MyInforms, 2 months ago
on your WebpageAdd Widget >Get your members hooked!